Det totale antal patienter, som havde en bivirkning, var 26, 0% og 28, 6% Bondenza 3 mg injektion hver 3. måned og 20, 4% og 22, 6% for oral ibandronsyre 2, 5 mg daglig efter henholdsvis et og to år.
The overall proportion of patients who experienced an adverse reaction was 26.0% and 28.6% for Bondenza 3 mg injection every 3 months and 20.4% and 22.6% for oral ibandronic acid 2.5 mg daily after one year and two years, respectively.